Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma

Correlation of molecular human leukocyte

Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon

✍ Helen Gogas; John M. Kirkwood; Christine S. Falk; Urania Dafni; Vernon K. Sondak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

## Abstract ## BACKGROUND: Interferon is approved for adjuvant treatment of patients with stage IIB/III melanoma. The identification of predictive markers that would permit selection of patients would be beneficial. Specific human leukocyte antigen (HLA) class I and II antigens have previously sho